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Abstract
The study objective was to identify facilitators and barriers of parental attitudes and beliefs toward 
school-located influenza vaccination in the United States. In 2009, the Advisory Committee on 
Immunization Practices of the Centers for Disease Control and Prevention expanded their 
recommendations for influenza vaccination to include school-aged children. We conducted a 
systematic review of studies focused on facilitators and barriers of parental attitudes toward 
school-located influenza vaccination in the United States from 1990 to 2016. We reviewed 11 
articles by use of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-
Analyses) framework. Facilitators were free/low cost vaccination; having belief in vaccine 
efficacy, influenza severity, and susceptibility; belief that vaccination is beneficial, important, and 
a social norm; perception of school setting advantages; trust; and parental presence. Barriers were 
cost; concerns regarding vaccine safety, efficacy, equipment sterility, and adverse effects; 
perception of school setting barriers; negative physician advice of contraindications; distrust in 
vaccines and school-located vaccination programs; and health information privacy concerns. We 
identified the facilitators and barriers of parental attitudes and beliefs toward school-located 
influenza vaccination to assist in the evidence-based design and implementation of influenza 
vaccination programs targeted for children in the United States and to improve influenza 
vaccination coverage for population-wide health benefits.
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INTRODUCTION
School-based health interventions have been implemented throughout the United States, 
with most school-based health clinics offering vaccination services to the general school 
community. In contrast, school-located vaccination (SLV) programs, and specifically school-
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located influenza vaccination (SLIV), are dedicated programs for targeted vaccination of 
school-aged children [1,2]. SLV programs have been adopted worldwide in countries such as 
Canada [3], the United Kingdom [4], and Australia [5]. While less common in the United 
States, school-located programs for influenza vaccination have shown success statewide in 
Hawaii [6] and in pilot studies in Tennessee [7] and Maryland communities [8].
Since the 2009 H1N1 influenza pandemic, SLIV programs have gained significant public 
health interest [1] for improving adolescent vaccination rates in non-clinical settings [9–12], 
potentially reducing emergency care visits for influenza-like illnesses, lowering community 
influenza risk, decreasing laboratory-confirmed cases, and improving school attendance 
[13,14]. In a modeling study by Weycker et al., authors found that vaccinating 20% of 
children in the United States decreased the total number of influenza cases in the total 
population by 46%, along with similar decreases in influenza-related mortality and 
economic costs [15]. However, because SLIV participation ultimately depends on parental 
consent, there is a need for enhanced understanding of parental attitudes and beliefs 
regarding SLIV in order to improve influenza vaccination rates among school children in the 
United States.
Study objective
Our study objective was to identify the facilitators and barriers of parental attitudes and 
beliefs toward school-located influenza vaccination in the United States, thereby assisting in 
the evidence-based design and implementation of current and future influenza vaccination 
programs targeted for children, by leveraging facilitators and addressing potential barriers of 
parental consent.
Public health significance
In 2009, the Advisory Committee on Immunization Practices (ACIP) of the Centers for 
Disease Control and Prevention expanded recommendations for targeted influenza 
vaccination by including school-aged children in the United States [16]. While this has 
improved vaccination coverage among children (6 months – 17 years) from 43.7% during 
the 2009–2010 influenza season to 59.3% during the 2015–2016 season [17], this is below 
the target of 70% in the Healthy People 2020 initiative [18].
Despite globally recognized benefits of school-located vaccination, the evidence base for 
SLIV acceptance in the United States is limited [11,12], with studies focused on clinical 
aspects of vaccine efficacy [19], program feasibility [20], and population-level benefits [21]. 
We conducted a systematic review to address this evidence gap to improve influenza 
vaccination coverage by identifying facilitators and barriers of parental attitudes and beliefs 
toward school-located influenza vaccination for children in the United States.
METHODS
Search strategy
We conducted our search using PubMed and Web of Science databases for articles written in 
the English language, published between 01/01/1990 to 10/01/2016, and contained the 
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following the terms: (influenza) AND (vaccine OR vaccination OR immunization) AND 
(school OR school-located OR school-based) AND (parent OR parental).
Data abstraction and synthesis
The data abstraction and synthesis process were conducted by two authors (GJK and RKC) 
independently; we resolved discordant decisions through consensus. Data abstraction and 
synthesis included the following four steps: identification, screening, eligibility, and 
inclusion. During the identification step, articles were identified using the aforementioned 
search strategy. During screening, duplicate articles were removed, and the titles and 
abstracts of the remaining articles were screened to determine relevance to our study 
objectives. During the eligibility step, article full text was analyzed to further determine 
relevance to our study objectives and to be used for inclusion.
Inclusion and exclusion criteria
We included articles that focused on childhood/adolescent age groups to target school-aged 
children in grades PreK-12 which met the following study criteria: 1) conducted qualitative 
and/or quantitative analysis regarding influenza vaccination for school-aged children in the 
United States; and 2) assessed parental factors associated with the acceptance, hesitancy, or 
refusal of utilizing school-located influenza vaccination for children, including parental 
knowledge, beliefs, and attitudes. We excluded studies that focused on general vaccine 
delivery (i.e. non-specific to influenza vaccine), studies of non-explicit parent populations 
(such as school personnel and health care workers who may also be parents), and studies 
taking place outside the United States.
PRISMA process
Figure 1 illustrates the process flow diagram of identification, screening, eligibility, and 
inclusion of articles for the systematic review, using the PRISMA (Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses) framework [22]. Eleven articles met our 
selection criteria for systematic review of facilitators and barriers of parental attitudes and 
beliefs toward school-located influenza vaccination in the United States. While we have 
included quantitative metrics of the clinical effect size of statistical association for each of 
the 11 studies, we have excluded quantitative synthesis using meta-analysis due to the 
heterogeneity in study design and population sampling of these 11 studies.
RESULTS
Characteristics of school-located influenza vaccination studies
We identified 11 articles focused on school-located influenza vaccination (SLIV) for 
analysis based on the inclusion and exclusion criteria of our systematic review. Table 1 
illustrates the objectives of the 11 studies, SLIV context (hypothetical or actual program 
context), school settings, geographic area, type of survey and/or focus group, parental 
sample sizes, and significant inferences regarding parental attitudes and beliefs of SLIV for 
school-aged children in the United States.
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Allison et al. surveyed elementary school parents in Salt Lake City, Utah and found that 
SLIV programs should address vaccine safety, benefit, cost, and convenience, while 
promoting vaccination as a social norm [9]. Brown et al. conducted an online survey of a 
nationally representative sample of parents, whose youngest child was less than 15 years old. 
While the convenience of SLIV promoted parental acceptance, parents preferred a medical 
location for proper administration and for care of potential medical needs and side effects. 
Vaccine safety was a significant barrier to consent [11]. Carpenter et al. briefly surveyed 
parents of large metropolitan public school system in Knoxville, Tennessee and found that 
significant barriers to SLIV participation included concerns regarding vaccine adverse 
effects and vaccine virus transmission to household members with health issues such as 
asthma [7]. A two-year survey conducted by Cheung et al. in urban elementary schools of 
Los Angeles County, California found that parents with better understanding of influenza 
risks and influenza vaccine benefits were more likely to consent to SLIV [23]. Gargano et al. 
surveyed middle and high school parents in Richmond County, Georgia and found that SLIV 
acceptance by parents correlated with parental beliefs of influenza vaccination being a social 
norm and perception of illness severity prevented by vaccination in general [24]. Kelminson 
et al. conducted a survey of parents in urban/suburban middle schools in Aurora, Colorado 
and found that belief in vaccine importance was associated with SLIV acceptance; parental 
absence during vaccination was a major barrier to consent [25]. Kempe et al. conducted a 
survey of public elementary school parents in a low-income area of Denver, Colorado and 
found that SLIV was strongly supported by parents due to belief in vaccine efficacy and 
convenience of school setting, while the barriers involved concerns regarding vaccine safety 
and parental absence during vaccination [26].
Focus group discussions of parents and students were conducted by Herbert et al. in a low-
income, rural county of Georgia; the barriers of non-participating parents in SLIV involved 
distrust, suspicions of the vaccination clinic, and the lengthy consent process [27]. 
Middleman et al. held focus groups of elementary, middle, and high school parents in a large 
urban school district of Houston, Texas and found that parental attitudes to SLIV were 
impacted by safety and trust issues regarding vaccines in general; programs should 
effectively communicate information regarding competency of health personnel 
administering the vaccine and equipment sterility [28]. In a related study, Middleman et al. 
conducted a survey of parent-student dyads in a large urban Houston school district; authors 
found that parental participation in SLIV was impacted by equipment sterility, universal 
access of vaccines for all students, and cost [12]. Lastly, Won et al. conducted a 2-year 
survey of middle school parents in a low-income urban school district and found that 
baseline trust in SLIV programs was moderately high among low-income parents, while 
higher trust and participation of SLIV may be attained by increasing parents’ perception of 
vaccine importance [29].
Facilitators
The facilitators of parental attitudes and beliefs toward SLIV in the United States are 
illustrated in Table 2 and described below.
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Cost—Parents were willing to participate in SLIV if they had no additional out-of-pocket 
expenses [9]. Free or low cost vaccines were significant facilitators of parental acceptance 
[28] but were less important when compared to other factors [12].
Vaccine efficacy—Parents with higher belief in vaccine efficacy were inclined to 
participate in SLIV [26].
Influenza severity—Parents with higher perceived severity of adolescent illness, 
including influenza, were more likely to accept SLIV [24]. Perceived severity of influenza 
illness was a predicting factor for parental consent [23].
Influenza illness susceptibility—Parental belief of their child being susceptible to 
influenza was a predicting factor of SLIV consent [23] and associated with acceptance if 
vaccines were offered for free [9]. Parents who had worried about the H1N1 virus in 2009 
were also more likely to consent to SLIV participation [11].
Vaccine benefits—Parents with higher perceived benefit of influenza vaccine protecting 
against illness [23], combined with stronger belief in vaccination as a social norm [24] were 
more inclined to accept SLIV. The belief in vaccine benefit was also associated with 
acceptance if vaccines were offered free of cost [9].
Vaccine importance—Parental perception of vaccine importance was directly correlated 
with acceptance and trust in SLIV [25,29].
Vaccination as a social norm—Social norms were associated with parental acceptance 
of school-located vaccination in general and for influenza vaccine specifically when 
compared to other adolescent vaccines [24]. Parental belief in vaccination as a social norm 
was associated with acceptance of SLIV if the vaccine was offered for free [9].
Influenza vaccine does not cause influenza—Parental belief in influenza vaccine not 
causing influenza was associated with acceptance of SLIV if the vaccine was offered for free 
[9].
Medical setting barriers—Endorsement of medical setting barriers such as 
inconvenience and time constraints promoted SLIV acceptance [9].
School setting advantages—Parents perceiving school-located vaccinations as 
convenient also facilitated SLIV acceptance [11,26–28].
Parental presence during vaccination—Flexible vaccination scheduling, such as 
during evenings or weekends, allowing parents to accompany children increased likelihood 
of SLIV participation [28].
Discussion with health care provider—Positive discussion about influenza 
vaccination and advice from a health care provider promoted parental consent and 
participation [9].
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Trust in school health personnel—Having knowledge of credentials and having trust 
in the competency of health personnel administering vaccines improved parental consent 
[28].
Universal vaccine access in school—Ensuring availability of influenza vaccines for 
all students was an important factor for parental acceptance—more important than offering 
free or low cost vaccines [12].
Barriers
The barriers of parental attitudes and beliefs toward SLIV in the United States are illustrated 
in Table 3 and described below.
Cost—Parents were less likely to participate in SLIV due to cost [25,26] especially with 
multiple children in the household [9], however, it was not a primary concern when 
compared to other barriers [28].
Vaccine safety—Parental concerns of vaccine safety in general, including influenza 
vaccine in particular [9,23,26], and risks [11] lowered their support to participate in SLIV.
Equipment sterility—Negative perceptions regarding sterility of equipment used for 
vaccine administration in a school setting was a significant factor impacting parental 
decision to trust and participate in SLIV [12].
Vaccine efficacy—Parents concerned with vaccine efficacy were less willing to 
participate in SLIV [9].
Influenza non-susceptibility—Parents with belief that their children were not 
susceptible to influenza were less likely to participate in SLIV [9].
Adverse effects—Parents concerned of vaccine side effects were less likely to consent to 
SLIV [23,27], with common concerns involving adverse effects of the live-attenuated 
influenza vaccine [7].
Influenza illness acquisition from vaccine—Parental concerns regarding influenza 
illness acquisition from the influenza vaccine was a barrier to SLIV participation [7].
Medical setting advantages—Parents preferred a medical setting for vaccination due to 
trust and safety issues regarding the child’s well-being [26,27], potential side effects, and for 
proper vaccine administration [11,23,28].
School setting barriers—Parental consent and acceptance of school vaccine delivery 
involved concerns regarding competency of person delivering the vaccine [9], the lengthy 
consent process [27], disorganization of the school [25], and the inability to address 
potential medical issues [28].
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Parental absence during vaccination—Parents wanting to be present during the 
child’s vaccination were less inclined to consent for SLIV in their absence [9,23] [26]. 
Parents who felt that their children would want them present during vaccination was also a 
notable barrier [25].
Discussion with health care provider—Receiving negative physician advice based on 
incorrect contraindications of the live-attenuated influenza vaccine deterred parental 
participation in SLIV [7].
Distrust of vaccines and vaccination programs—Parents expressing skepticism of 
the influenza vaccine and/or the school-located vaccination program opted to either 
vaccinate their children through primary care physicians and pharmacies, or forgo influenza 
vaccination entirely. Negative attitudes toward the university-implemented vaccination 
program and associated misperceptions of research being performed on their children (i.e. to 
test an experimental vaccine) was a distinct barrier to SLIV participation [27].
Health insurance information—Parents were unwilling to provide health insurance 
information for billing, acting as a barrier to SLIV participation [26].
Health information privacy—Parents who were uncertain of the use/misuse of health 
information collected from their children’s medical records were reluctant to consent to 
SLIV [27].
Pharmaceutical company—Poor communication and lack of knowledge regarding the 




Our review found that free or low cost vaccines generally facilitated parental acceptance of 
school-located influenza vaccination (SLIV) [9,12,28]. Parental acceptance is likely to be 
further facilitated by the Affordable Care Act [30] of 2010 which requires influenza (and 
other vaccines) to be covered by health insurance without charging a copayment or 
coinsurance, and the uninsured rate have declined by 43% from 16.0% in 2010 to 9.1% in 
2015 [31]. Parents perceiving the convenience of a school setting over medical settings for 
vaccination were relatively more likely to consent [9,11,26–28]; having a positive discussion 
with a health care provider [9] and trusting the competency of health personnel 
administering the vaccine [28] significantly enhanced parental attitudes and acceptance for 
SLIV programs. Parents also preferred the scheduling of SLIV to take place after school or 
during weekends to allow parents the ability to accompany children during vaccination [28]. 
Additionally, the availability of influenza vaccines for all students was an important factor 
for parents [12,28].
Studies utilizing the Health Belief Model (HBM) [32] suggested that parents with enhanced 
perceptions of influenza susceptibility and severity, risks of H1N1 influenza, and benefits of 
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influenza vaccination (including belief that the influenza vaccine does not cause influenza) 
were more likely to accept SLIV for their children [9,23,24,26]. Having beliefs in vaccine 
efficacy [26], vaccine importance [25,29], and vaccination as a social norm [9,24] also 
promoted SLIV acceptance among parents. While most parents accepting of vaccines also 
consented to SLIV, some parents with no intention of vaccinating for influenza also stated 
willingness to participate if SLIV became available [9,24].
Barriers
Significant barriers to SLIV acceptance were often related to the elements of the influenza 
vaccine, including concerns regarding vaccine safety [9,11,12,23,26,28], vaccine efficacy 
[9], vaccine adverse effects [7,23,27], and the risk of influenza acquisition from the vaccine 
itself [7].
Parental distrust of the school-located vaccination program was a notable barrier to 
participation, particularly for SLIV implemented by an external entity in a school setting 
without a health clinic [27]. Vaccine trust issues involved skeptical attitudes toward the 
vaccine [11,27,28], concerns regarding equipment sterility and cleanliness of the school 
location [12,28], and lacking knowledge of the pharmaceutical company that manufactured 
the vaccine [28]. Parents were unwilling to provide health insurance information for billing 
[26], and due to distrust in the vaccination program, parents felt uncertain regarding use/
misuse of health information collected from medical records of their children [27].
Trust issues, safety concerns, and medical setting advantages presented barriers for 
vaccination within a school setting [11,23,26–28]. Common concerns involved competency 
of health personnel administering the vaccine and their ability to address potential medical 
issues in a school setting [9,25,27,28]; many parents did not want their children to receive 
vaccination in their absence [9,23,25,26]. Other barriers included parental belief that their 
children were not susceptible to influenza [9] and having received physician advice that 
negatively portrayed live-attenuated influenza vaccination due to an incorrect understanding 
of contraindications [7]. Lastly, vaccine cost was generally perceived as a minor barrier for 
parents [9,25,26,28].
School-located influenza vaccination in school-based clinics versus delivery by external 
agencies
The studies included in this systematic review assessed parental attitudes and beliefs in 
relation to hypothetical SLIV scenarios and pilot program contexts. The pilot studies 
summarized here utilized external agencies such as health departments [7,23,26], university 
research staff [27], and hospitals [29] to deliver influenza vaccination in schools, as opposed 
to utilizing a school-based health clinic that is offered year-round; these two scenarios may 
present different issues of trust and concern among parents. Due to considerable 
heterogeneity in the format of school-located vaccination programs [25], future SLIV 
programs should take various scenarios into consideration during planning phases.
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Studies in this review reported limitations of low response rates [7,11,12,23,24,29], limited 
generalizability [9,11,12,23,24,26–29], and potential selection bias [12,23–25,28]. Some 
studies were geared towards hypothetical SLIV programs in the future [11,12,25], and 
thereby, the responses of parents were based on potential action rather than actual behavior.
Differences in survey development, analysis, and subjective interpretation of qualitative 
responses of parents by authors limited comparability across studies as well as prioritization 
of parental barriers and facilitators. However, study findings encompass diversely varied 
populations and geographic regions within the United States which provides collective 
insight for potential prioritization within specific communities.
While the review of literature in this study is from 1990 to 2016, publication dates of 
reviewed articles span from 2007 to 2015, with only two studies conducted before the 2009 
H1N1 influenza pandemic. Thus, the analysis timeline of this systematic review may be 
biased towards studies after the 2009 H1N1 pandemic and possibly reflect elevated 
awareness of influenza among parental attitudes and beliefs toward SLIV programs. 
Additionally this may be reflective of the nature of discourse surrounding recent utilization 
of school-located immunization programs, signifying a young and evolving concept and area 
which necessitates further study.
Public health implications
Effective from the 2010–2011 influenza season, the ACIP recommends seasonal influenza 
vaccination annually for individuals aged 6 months and older without contraindications to 
prevent and control seasonal and pandemic influenza [33]. The Healthy People 2020 
initiative includes the target of influenza vaccination coverage of 70% [18]. Yet, influenza 
vaccination coverage in the general population was below par, ranging from 36.8% in 
Nevada to 56.6% in South Dakota during the 2015–2016 influenza season, with a national 
vaccination coverage among children (6 months – 17 years) of 59.3% [34]. In this 
systematic review, we identified the facilitators and barriers of parental attitudes and beliefs 
toward SLIV for children in the United States that can assist in improving coverage and 
effectiveness of SLV programs. Specifically, influenza vaccination coverage is improved 
among children whose parents did not plan to vaccinate in the absence of a school-located 
program [9,24]. Further, improving influenza vaccination coverage among school children in 
general improves herd immunity in the total population. The Affordable Care Act [30] of 
2010 lowered the uninsured rate by 43% from 16.0% in 2010 to 9.1% in 2015 [31], and 
health insurance now covers influenza vaccines without additional out-of-pocket payments. 
While cost has become a lesser barrier, SLV programs can facilitate improved access to 
influenza vaccination for school-aged children.
Systems thinking in school-located influenza vaccination
Health program strategies based on systems thinking focus on an ongoing iterative learning 
of systems understanding, analysis and improvement, and leadership and collaboration 
across disciplines, sectors, and organizations [35]. School-located influenza vaccinations are 
collaborative programs between health and education sectors with great potential for 
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improving influenza vaccination coverage among school-aged children. SLIV programs 
directly benefit vaccinated children who express protective immune response, as well as 
indirectly benefiting the larger community by reducing transmission pathways. We identified 
facilitators and barriers of parental attitudes and beliefs toward SLIV from a systems 
thinking perspective. Through systematic understanding, analysis, and identification of 
facilitators and barriers, this study provides evidence to improve the design and 
implementation of current and future SLIV programs by leveraging key promoting factors 
and addressing potential barriers.
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Figure 1. PRISMA flowchart
The Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) flow 
diagram of articles’ identification, screening, eligibility, and inclusion in the systematic 
review is illustrated. Articles focused on the facilitators and barriers of parental attitudes and 
belief towards school-located influenza vaccination in the United States were included, 
while articles focused on non-influenza vaccination, non-parent population, and regions 
outside of United States were excluded.
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Table 2
Facilitators
Facilitators of parental attitudes and beliefs toward school-located influenza vaccination (SLIV) in the United 
States.
Promoting Factor Description Study
Cost Offering free/low cost vaccines [9,12,28]
Vaccine efficacy Belief in vaccine efficacy [26]
Influenza severity Belief in perceived severity of influenza [23,24]
Influenza illness susceptibility Parental belief in children being susceptible to influenza and risk concerns of 
H1N1 influenza
[9,11,23]
Vaccine benefits Belief in benefit of influenza vaccine to protect against influenza illness [9,23,24]
Vaccine importance Belief in importance of vaccination in general [25,29]
Vaccination is a social norm Belief that vaccination is a social norm [9,24]
Influenza vaccine does not cause influenza Belief that the influenza vaccine does not cause influenza [9]
Medical setting barriers Perception of inconvenience in accessing regular medical settings for vaccination [9]
School setting advantages Perception of convenience in accessing school setting for vaccination [11,26–28]
Parental presence during vaccination Parents being present during vaccination after school or during weekends [28]
Discussion with health care provider Positive discussion with health care provider about influenza vaccination [9]
Trust in school health personnel Trust in competency of health personnel administering the influenza vaccine [28]
Universal vaccine access in school Access and availability of influenza vaccine for all students in school [12,28]
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Table 3
Barriers
Barriers of parental attitudes and beliefs toward school-located influenza vaccination (SLIV) in the United 
States.
Barrier Description Study
Cost Concerns of potential billing related to school-located vaccination [9,25,26,28]
Vaccine safety Safety concerns of vaccines in general, including the influenza vaccine [9,11,12,23,26,28]
Equipment sterility Trust concerns of cleanliness and sterility of equipment used for vaccination [12,28]
Vaccine efficacy Concerns of vaccine efficacy [9]
Influenza non-susceptibility Parental belief that their children are not susceptible to influenza [9]
Adverse effects Concerns of adverse effects from vaccination [7,23,27]
Influenza illness acquisition from 
vaccine
Concerns of acquisition of influenza illness from influenza vaccine [7,26]
Medical setting advantages Parents preferred vaccination at regular medical settings for trust and safety 
reasons
[11,23,26–28]
School setting barriers Concerns regarding competency of person administering the vaccine, school 
disorganization, and inability to address medical issues
[9,25,27,28]
Parental absence during vaccination Parents did not want their children to receive vaccinations in their absence [9,23,25,26]
Discussion with health care provider Negative physician advice based on incorrect live-attenuated influenza 
vaccine contraindications and concerns of vaccine virus transmission to 
household members with health issues such as asthma
[7]
Distrust of vaccines and vaccination 
programs
Distrust and skepticism about the vaccination program and vaccines in 
general, including influenza vaccine.
[27,28]
Health insurance information Unwillingness of parents to provide health insurance information [26]
Health information privacy Privacy concerns of use/misuse of collected medical information and distrust 
of vaccination program
[27]
Pharmaceutical company Lack of knowledge of pharmaceutical company manufacturing the influenza 
vaccine
[28]
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